Zai Lab Ltd. Unsponsored ADR Stock

$27.06

1.46% yesterday

Nasdaq, Nov 15, 10:00 pm CET

ISIN

US98887Q1040

Symbol

ZLAB

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Biotechnology

Overview Dividends Analysts Charts News Strategies

Zai Lab Ltd. Unsponsored ADR Stock price

$27.06

-11.87 30.49% 5Y

Nasdaq, Closing price Fri, Nov 15 2024

+0.39 1.46%

ISIN

US98887Q1040

Symbol

ZLAB

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Biotechnology

Key metrics

Market capitalization	$2.68b
Enterprise Value	$2.09b
P/E (TTM) P/E ratio	negative
EV/FCF (TTM) EV/FCF	negative
EV/Sales (TTM) EV/Sales	5.88
P/S ratio (TTM) P/S ratio	7.54
P/B ratio (TTM) P/B ratio	3.99
Revenue growth (TTM) Revenue growth	35.01%
Revenue (TTM) Revenue	$355.75m
EBIT (operating result TTM) EBIT	$-338.21m
Free Cash Flow (TTM) Free Cash Flow	$-178.00m
Cash position	$716.09m
EPS (TTM) EPS	$-2.78
P/E forward	negative
P/S forward	6.78
EV/Sales forward	5.27
Short interest	5.39%

As a Free StocksGuide user, you can view scores for all 6,897 stocks worldwide.

Get Started for Free Today

Zai Lab Ltd. Unsponsored ADR Stock Analysis

Unlock Scores for Free

??

15 Analysts have issued a Zai Lab Ltd. Unsponsored ADR forecast:

13x Buy

87%

More details on Analyst Estimates Including Price Targets

15 Analysts have issued a Zai Lab Ltd. Unsponsored ADR forecast:

Buy

87%

Hold

13%

Analyst Estimates with Stock Price Targets

Financial data from Zai Lab Ltd. Unsponsored ADR

Income Statement P&L | Balance Sheet | Cash Flow

Quarter TTM Annually

Sep '24		+/- %
Revenue	356 356	35% 35% 100%
- Direct Costs	131 131	43% 43% 37%
Gross Profit	225 225	31% 31% 63%
- Selling and Administrative Expenses	279 279	10% 10% 79%
- Research and Development Expense	264 264	5% 5% 74%
EBITDA	-319 -319	4% 4% -90%
- Depreciation and Amortization	19 19	9% 9% 5%
EBIT (Operating Income) EBIT	-338 -338	3% 3% -95%
Net Profit	-271 -271	10% 10% -76%

In millions USD.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Subscribe Now

Zai Lab Ltd. Unsponsored ADR Stock News

Neutral

Business Wire

●

one day ago

Zai Lab Announces Pricing of Public Offering of American Depositary Shares

SHANGHAI & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zai Lab Limited (“Zai Lab” or the “Company”) (NASDAQ: ZLAB; HKEX: 9688), an innovative, commercial-stage biopharmaceutical company, today announced the pricing of its underwritten public offering of 7,843,137 American depositary shares (“ADSs”), each representing ten ordinary shares of the Company, at a price of US$25.50 per ADS. The gross proceeds ...

Neutral

Business Wire

●

2 days ago

Zai Lab Announces Proposed Public Offering of American Depositary Shares

SHANGHAI & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zai Lab Limited (“Zai Lab” or the “Company”) (NASDAQ: ZLAB; HKEX: 9688), an innovative, commercial-stage biopharmaceutical company, today announced that it has commenced an underwritten public offering of $200.0 million of American depositary shares (“ADSs”), each representing ten ordinary shares of the Company with a par value of $0.000006 per shar...

Neutral

Seeking Alpha

●

3 days ago

Zai Lab Limited (ZLAB) Q3 2024 Earnings Call Transcript

Zai Lab Limited (NASDAQ:ZLAB ) Q3 2024 Earnings Conference Call November 12, 2024 8:00 AM ET Company Participants Christine Chiou - Senior Vice President, Investor Relations Samantha Du - Founder, Chairperson and Chief Executive Officer Josh Smiley - President and Chief Operating Officer Rafael Amado – President, Head of Global Research and Development Yajing Chen - Chief Financial Officer Conf...

More Zai Lab Ltd. Unsponsored ADR News

Company Profile

Zai Lab Ltd. is a biopharmaceutical company, which engages in the licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need. Its product pipelines include ZL-2306, ZL-2401, FPA144, ETX2514, and ZL-2301. The company was founded by Samantha Ying Du and Marietta Wu in 2014 and is headquartered in Shanghai, China.

Head office	Cayman Islands
CEO	Ying Du
Employees	2,175
Founded	2014
Website	www.zailaboratory.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now